Pembrolizumab plus docetaxel for the treatment of recurrent metastatic head and neck cancer: A prospective phase I/II study

被引：1
|
作者：
Fuereder, T. [1 ]
Minichsdorfer, C. [1 ]
Mittlboeck, M. [2 ]
Wagner, C. [1 ]
Oberndorfer, F. [3 ]
Mullauer, L. [3 ]
Aretin, M-B. [4 ]
Czerny, C. [5 ]
Schwarz-Nemec, U. [5 ]
机构：
[1] Med Univ Vienna, Vienna Gen Hosp, Internal Med I, Vienna, Austria
[2] Med Univ Vienna, Vienna Gen Hosp, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria
[3] Med Univ Vienna, Vienna Gen Hosp, Pathol, Vienna, Austria
[4] Vienna Gen Hosp, Pharm, Vienna, Austria
[5] Med Univ Vienna, Vienna Gen Hosp, Biomed Imaging & Image Guided Therapy, Vienna, Austria
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1036
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
921P
引用
收藏
页码：S665 / S665
页数：1
相关论文
共 50 条
  • [41] Phase I/II study of docetaxel, cisplatin and S-1 in locally advanced, recurrent and metastatic head and neck squamous cell carcinoma
    Tada, Yuichiro
    Maruya, Shin-Ichiro
    Saotome, Takashi
    Miura, Kouki
    Masubuchi, Tatsuo
    Fushimi, Chihiro
    Okamoto, Isaku
    Takeishi, Etsuro
    Yamada, Shuhei
    Asai, Hiroaki
    Kamata, Shin-Etsu
    ONCOLOGY LETTERS, 2012, 4 (05) : 898 - 904
  • [42] A phase II study evaluating axitinib in patients with unresectable, recurrent or metastatic head and neck cancer
    Swiecicki, Paul L.
    Zhao, Lili
    Belile, Emily
    Sacco, Assuntina G.
    Chepeha, Douglas B.
    Dobrosotskaya, Irina
    Spector, Matthew
    Shuman, Andrew
    Malloy, Kelly
    Moyer, Jeffrey
    McKean, Erin
    McLean, Scott
    Wolf, Gregory T.
    Eisbruch, Avraham
    Prince, Mark
    Bradford, Carol
    Carey, Thomas
    Worden, Francis P.
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (06) : 1248 - 1256
  • [43] Pembrolizumab plus nab-paclitaxel and platinum as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (R/M HNSCC): A prospective phase II study
    Gui, L.
    Chen, X.
    He, X.
    Yang, J.
    Liu, P.
    Qin, Y.
    Shi, Y-K.
    ANNALS OF ONCOLOGY, 2023, 34 : S1609 - S1610
  • [44] Docetaxel plus cetuximab biweekly is an active regimen for the first-line treatment of patients with recurrent/metastatic head and neck cancer
    Doris Posch
    Hannah Fuchs
    Gabriela Kornek
    Anja Grah
    Johannes Pammer
    Marie-Bernadette Aretin
    Thorsten Fuereder
    Scientific Reports, 6
  • [45] Docetaxel plus cetuximab biweekly is an active regimen for the first-line treatment of patients with recurrent/metastatic head and neck cancer
    Posch, Doris
    Fuchs, Hannah
    Kornek, Gabriela
    Grah, Anja
    Pammer, Johannes
    Aretin, Marie-Bernadette
    Fuereder, Thorsten
    SCIENTIFIC REPORTS, 2016, 6
  • [46] A randomized phase II study of docetaxel with or without vandetanib in recurrent or metastatic squamous cell carcinoma of head and neck (SCCHN)
    Limaye, Sewanti
    Riley, Sarah
    Zhao, Sihai
    O'Neill, Anne
    Posner, Marshall
    Adkins, Douglas
    Jaffa, Zachary
    Clark, John
    Haddad, Robert
    ORAL ONCOLOGY, 2013, 49 (08) : 835 - 841
  • [47] A phase II trial of perifosine in patients with recurrent or metastatic head and neck cancer
    Argiris, A
    Cohen, EEW
    Wade, J
    Mauer, A
    Gustin, D
    Ansari, R
    Wong, S
    Karrison, T
    Vokes, E
    LUNG CANCER, 2004, 46 : S66 - S66
  • [48] QOL in a prospective phase I/II study of accelerated radiotherapy for head and neck cancer
    Ringash, J
    Waldron, J
    Gitterman, L
    Sellmann, S
    Lockwood, G
    Warde, P
    Bayley, A
    Cummings, B
    Kim, J
    Payne, D
    O'Sullivan, B
    RADIOTHERAPY AND ONCOLOGY, 2005, 76 : S41 - S42
  • [49] A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck
    Couteau, C
    Chouaki, N
    Leyvraz, S
    Oulid-Aissa, D
    Lebecq, A
    Domenge, C
    Groult, V
    Bordessoule, S
    Janot, F
    De Forni, M
    Armand, JP
    BRITISH JOURNAL OF CANCER, 1999, 81 (03) : 457 - 462
  • [50] A phase II study of docetaxel in patients with metastatic squamous cell carcinoma of the head and neck
    C Couteau
    N Chouaki
    S Leyvraz
    D Oulid-Aissa
    A Lebecq
    C Domenge
    V Groult
    S Bordessoule
    F Janot
    M De Forni
    J-P Armand
    British Journal of Cancer, 1999, 81 : 457 - 462
12345